John Lambert
EXECUTIVE CHAIRMAN
vaccine industry.
Widewaters
United Kingdom
Biography
John contributes significant experience of leadership at a senior level within the vaccine industry.
Research Interest
John Lambert has a wealth of experience in the vaccine industry including as President of Chiron Vaccines ahead of its acquisition by Novartis. Prior to Chiron, John was President of Aventis Pasteur MSD, the joint vaccine business of Merck and Sanofi Pasteur in Europe